OrthoPediatrics Corp. KIDS 深 沪
等待开盘 06-02 09:30:00 美东时间
16.795
-0.375
-2.18%
华盛通- 最 高17.3264
- 今 开16.95
- 成交量 6.14万股
- 最 低 16.71
- 昨 收 17.17
- 总市值 4.31亿
- 52周最高 23.70
- 市盈率 静 --
- 换手率 0.24%
- 52周最低 14.42
- 委 比 85.31%
- 总股本 2568.50万
- 历史最高 73.91
- 量 比 0.88
- 振 幅 3.59%
- 历史最低 14.00
- 每 手 1
- 风险率 1.93%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多OrthoPediatrics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
OrthoPediatrics Corp. announced that Fred Hite, its Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, in Miami Beach, FL. The discussion will be audio webcast on OrthoPediatrics’ investor relations website, with a replay available afterward. OrthoPediatrics, founded in 2006, focuses exclusively on pediatric orthopedics, offering n...
05-26 20:05
美股大行评级 | 苹果获多家机构上调目标价，最高至335美元；闪迪获华尔街大行看多至2000美元
今日重点评级关注：Benchmark：维持史密斯微软件"买入"评级，目标价从2美元升至2.5美元；Citizens：维持DBV Technologies"跑赢大市"评级，目标价从47美元升至55美元
05-04 16:04
BTIG Reiterates Buy on OrthoPediatrics, Maintains $24 Price Target
BTIG analyst Ryan Zimmerman reiterates OrthoPediatrics (NASDAQ:KIDS) with a Buy and maintains $24 price target.
05-01 18:48
电话会总结 ｜ OrthoPediatrics(KIDS)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据OrthoPediatrics业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 2026年第一季度全球总收入5,940万美元，同比增长13% - 美国收入4,530万美元，同比增长11%，占总收入76% - 国际收入1,410万美元，同比增长22%，占总收入24% **分业务收入：** - 创伤与畸形矫正(T&D)全球收入4,300万美元，同比增长14% - 脊柱侧弯全球收入1,540万美元，同比增长13% - 运动医学/其他收入90万美元，与去年同期持平 **盈利能力：** - 毛利率73%，与去年同期持平 -
05-01 12:05
OrthoPediatrics Q1 2026 Earnings Call: Complete Transcript
On Thursday, OrthoPediatrics (NASDAQ:KIDS) discussed first-quarter financial re...
05-01 05:51
OrthoPediatrics Raises FY2026 Sales Guidance from $262.000M-$266.000M to $263.000M-$267.000M vs $264.310M Est
OrthoPediatrics (NASDAQ:KIDS) raises FY2026 sales outlook from $262.000 million-$266.000 million to $263.000 million-$267.000 million vs $264.310 million estimate.
05-01 04:13
OrthoPediatrics Q1 Adj. EPS $(0.42) Beats $(0.48) Estimate, Sales $59.362M Beat $58.315M Estimate
OrthoPediatrics (NASDAQ:KIDS) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.48) by 12.5 percent. This is a 7.69 percent decrease over losses of $(0.39) per share from the
05-01 04:12
OrthoPediatrics Expands Specialty Bracing Portfolio with TRAXIO Halo Gravity Traction System
OrthoPediatrics Corp. has expanded its OrthoPediatrics Specialty Bracing portfolio with the launch of the TRAXIO Complete - Weight System, developed in collaboration with Synetik Group. The TRAXIO system provides controlled, weight-based axial traction for spinal realignment in infants, children, and adolescents, supporting halo gravity traction therapy in hospital settings. Joe Hauser, President of OrthoPediatrics Specialty Bracing, highlighted ...
04-30 20:01
Earnings Scheduled For April 30, 2026
Companies Reporting Before The Bell • Sonic Automotive (NYSE:SAH) is projected ...
04-30 19:11
OrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026
OrthoPediatrics Corp. will release its Q1 2026 financial results on April 30, 2026 after market close. A conference call to discuss the results will be held at 4:30 p.m. ET on the same day. Investors can access a live or archived webcast via the company's website at www.orthopediatrics.com under the Investors section. OrthoPediatrics, founded in 2006, focuses exclusively on pediatric orthopedics, offering over 85 products in trauma, deformity, sc...
04-16 20:05
